Ventyx Biosciences, Inc. (VTYX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:07PM EDT. Market open.
| Previous close | 4.8500 |
| Open | 4.9000 |
| Bid | 4.7200 x 100 |
| Ask | 4.7900 x 100 |
| Day's range | 4.7200 - 4.9950 |
| 52-week range | 1.8650 - 40.5800 |
| Volume | |
| Avg. volume | 4,115,056 |
| Market cap | 336.331M |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What Makes Ventyx Biosciences (VTYX) a New Buy Stock
Ventyx Biosciences (VTYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Simply Wall St.
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- GuruFocus.com
Ventyx Biosciences Inc CEO Raju Mohan Sells 58,860 Shares
Raju Mohan, CEO and President of Ventyx Biosciences Inc, executed a sale of 58,860 shares in the company on December 20, 2023, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.